Annals ofRheumatology

Volume: 4 - Number: 33 - June 15, 2004

Outstanding

Tumor Necrosis Factor Inhibitors "SPARCC" an Interest in Consensus

When Is Scleroderma Really Scleroderma?

Where There's Smoke There's Fire: The Silicone Breast Implant Controversy Continues to Flicker: A New Disease That Needs To Be Defined

Who Should Look After Patients with Mild Lupus?

Editorial

The Possible Clinical Application of Pharmacogenetics in Rheumatology

The Psychometrics of Functional Status Questionnaires: Room for Improvement

The Rewards of Taking a Hard Look at the Practice of Rheumatology

The Spectrum of the Antiphospholipid Syndrome: A Matter of Perspective

The Use of Biochemical Markers of Bone and Cartilage Metabolism to Monitor Osteoarthritis — Dreams and Reality

The Use of Etanercept and Other Tumor Necrosis Factor-a Blockers in Infertility: It's Time to Get Serious

Treatment of Refractory Juvenile Idiopathic Arthritis

Treatment of Rheumatoid Arthritis 2002

Treatment Related Mortality versus Quality of Life -- A Balancing Act

Tumor Necrosis Factor Inhibitors "SPARCC" an Interest in Consensus

Uveitis Associated with Juvenile Idiopathic Arthritis: Envisioning the Future

Varus Knee Osteoarthritis: Whence the Varus?

What Does Cartilage Calcification Tell Us About Osteoarthritis?

When Is Scleroderma Really Scleroderma?

When, Why, and How Should We Quantify the Excretion Rate of Urinary Uric Acid?

Where There's Smoke There's Fire: The Silicone Breast Implant Controversy Continues to Flicker: A New Disease That Needs To Be Defined

Whiplash and the Clinician

Who Should Look After Patients with Mild Lupus?

WHO-ILAR COPCORD Perspectives Past, Present, and Future

WOMAC: A 20-Year Experiential Review of a Patient-Centered Self-Reported Health Status Questionnaire